Orion Asset Management
 

Investment Options

Trilogy offers two main investment options:

Global Equities

Emerging Markets Equities

  • Portfolios are constructed with securities listed on global exchanges.

Investment Products

The above investment options can be accessed via the following products:

Segregated Mandates

Segregated mandates are available for Trilogy's Global Equites and Emerging Markets Equities for a minimum investment of AUD $75 million.

Wholesale Funds

The following wholesale pooled funds are also available for investors with a minimum investment of AUD $500,000 - these are:
  • Trilogy Global Equities Fund
  • Trilogy Concentrated Global Equities Fund
  • Trilogy Emerging Markets Equities Fund

To view the Product Features of these funds, please click here

For more information on these funds, please click here to go to our Product Disclosure Statements page.

Wholesale Funds Product Features

The Trilogy Global Equities Fund, the Trilogy Concentrated Global Equities Fund and the Trilogy Emerging Markets Equities Fund were launched in November 2006, and provide investors with an opportunity to invest in global equity securities and cash.

Trilogy actively manages the portfolios according to their bottom-up, growth orientated investment style. This is based on the belief that future earnings growth is a key determinant of long-term equity returns.

For more information on these funds, please click here to go to our Product Disclosure Statements page.

 
 

 

IMPORTANT INFORMATION

Treasury Group Investment Services Limited (TIS) is the Responsible Entity for the Trilogy Global Equities Fund, the Trilogy Concentrated Global Equities Fund and the Trilogy Emerging Markets Equities Fund (the “Funds”). Applications can only be made on the form in the current Product Disclosure Statement dated 15 April 2009. A Product Disclosure Statement is available by contacting Orion Asset Management (Orion) or at www.orionfunds.com.au. Potential investors should consider the Product Disclosure Sstatement before deciding whether to invest, or continue to invest, in the Funds. The offer of units in the Funds made in the Product Disclosure Statement is available to persons recieving the Product Disclosure Statement within Australia (including electronic form). The Product Disclosure Statement does not constitute an offer or invitation in any place outside Australia where, or to any person whom, it would be unlawful to make such an offer or invitation.

Investors should be aware that past performance is not indicative of future performance. Returns can be volatile, relfecting rises and falls in the value of underlying investments. Potential investors should seek independent advice as to the suitability of the Funds to their investment needs.

Orion and Trilogy Global Advisors (Trilogy) each receive an investment management fee based on the amount invested in the Fund in return for managing the Trilogy Global Equities Fund, the Trilogy Concentrated Global Equities Fund and the Trilogy Emerging Markets Equities Fund. See the Product Disclosure Statements for more details.

TIS, Orion and Trilogy employees, authorised representatives and directors are paid a salary. They are not paid any commissions but may be paid a bonus based on the performance of the individual, TIS, Orion and/or Trilogy (as the case may be).

While the information contained on this website has been prepared with all reasonable care, niether Orion Asset Management Limited or Trilogy Global Advisors accept any responsibility or liability for any errors, omissions or misstatements however caused. This information is not personal advice. This information has been prepared without taking account of your objectives, financial situation or needs.

TIS may be contacted by writing to level 5, 50 Margaret Street, Sydney, NSW 2000, by fax (02) 8243 0410 or by telephone (02) 8243 0400.

 

© ORION Asset Management Limited ABN 91 092 873 160 * AFS Licence Number: 232379 * another Treasury Group initiative
 * terms of use * privacy policy * disclaimer *